Trial Details

RECRUITING
Basic Information
Clinical ID c374
Identifier NCT06696014
Trial Title Mirikizumab Real World Protocol
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions -
Participant Information
Sponsor University of North Carolina, Chapel Hill
City Denver
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2025-05-08
Primary Completion Date 2030-01-01
Completion Date 2030-01